Clinical

Automated dispensing cabinets (ADCs) have helped in monitoring quality-assurance data, particularly related to dispensation and diversion of controlled substances. This article describes the characteristics of controlled substance discrepancies found at a Level I trauma hospital among Medicare patients and the use of an ADC at the medical facility.
Dramatic Increase in Misuse of Controlled Substances a Concern for All Stakeholders
Chronic obstructive pulmonary disease (COPD) is characterized by persistent, progressive airflow limitation that is not fully reversible. This study analyzed the effects of early versus delayed initiation of roflumilast treatment after a hospital or emergency department discharge resulting from COPD exacerbation.
Continuing Challenges in COPD Management, Despite Its Prevalence and High Economic Burden
Hepatitis C is a disease of the liver resulting from infection by the hepatitis C virus (HCV). HCV infection is blood-borne and can result in an acute illness, with severity ranging from mild (little or no symptoms) to severe (symptoms requiring hospitalization).
Taking Steps to Cure Chronic Hepatitis C Virus Infection
Health professionals are increasingly encouraged to involve patients in their treatment decisions, recognizing that patients are experts in terms of their preferences and have unique knowledge of their own health.
Challenges in the Assessment of Patient Preferences among RA Therapies
The new proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors can have significant budget effects, depending on the breadth of the US Food and Drug Administration (FDA)’s approved labeling. American Health & Drug Benefits asked Stephen Gorshow, MD, and James T. Kenney, RPh, MBA, to participate in a teleconference to better understand how payers are approaching the management of these agents.
Major pharmaceutical companies currently devote substantial resources to detailing activities for their major products, with estimated annual spending of $7 billion to $20 billion.
Improving Patient Outcomes and Drug Prescribing Cost-Effectiveness Through Academic Detailing
Many believe that proprotein convertase subtil­isin/kexin type 9 (PCSK9) inhibitors are the pharmacotherapeutic innovation of the decade for prevention of cardiovascular (CV) events.
For many years, disease­modifying antirheumatic drugs (DMARDs) have been the mainstay of RA treatment, reducing inflammation and preventing further joint deterioration and disease progression. In the past 15 years, biologic DMARDs have become available and have proved effective for reducing inflammation and managing the disease.
You Cannot Manage What You Cannot Measure
During the past 15 years, advances in the treatment of relapsing-remitting multiple sclerosis (RRMS) have reshaped the way clinicians and patients approach this disabling chronic disorder.
Drugs for hypercholesterolemia represent 1 of the 10 most widely prescribed pharmaceutical classes in the United States. Rosuvastatin ranks second among the most widely prescribed drugs, with 21.4 million total prescriptions monthly as of March 2015.
Page 3 of 11
Results 21 - 30 of 104
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME